Over-expression of major colonization factors of enterotoxigenic Escherichia coli, alone or together, on non-toxigenic E. coli bacteria - PubMed

Affiliations

• PMID: 20728524
• DOI: 10.1016/j.vaccine.2010.08.047

Over-expression of major colonization factors of enterotoxigenic Escherichia coli, alone or together, on non-toxigenic E. coli bacteria

Joshua Tobias et al. Vaccine. 2010.

Abstract

Enterotoxigenic Escherichia coli (ETEC) is an important cause of diarrheal disease and deaths among children in developing countries and the major cause of traveller's diarrhea. Since surface protein colonization factors (CFs) of ETEC are important for pathogenicity and immune protection is mainly mediated by locally produced IgA antibodies in the gut, much effort has focused on the development of an oral CF-based vaccine. We have recently described the development of recombinant strains over-expressing CFA/I; the most prevalent CF among human clinical ETEC isolates. Here, non-toxigenic recombinant E. coli strains over-expressing Coli surface antigen 2 (CS2), CS4, CS5, and CS6, either alone, or each in combination with CFA/I were constructed by cloning the genes required for expression and assembly of each CF into expression vectors harboring a strong promoter. Immunological assays showed that recombinant strains expressing single CFs produced those in significantly larger amounts than did corresponding naturally high producing reference strains. Recombinant strains co-expressing CFA/I together with another CF also expressed significantly larger amounts of both CFs compared with the corresponding references strains. Further, when tested in mice, oral immunization with formalin-killed recombinant bacteria co-expressing one such double-expression CF pair, CFA/I+CS2, induced specific serum IgG+IgM and fecal IgA antibody responses against both CFs exceeding the responses induced by immunizations with natural reference strains expressing CFA/I and CS2, respectively. We conclude that the described type of recombinant bacteria over-expressing major CFs of ETEC, alone or in combination, may be useful as candidate strains for use in an oral whole-cell CF-ETEC vaccine.

Similar articles

• Construction of a non-toxigenic Escherichia coli oral vaccine strain expressing large amounts of CS6 and inducing strong intestinal and serum anti-CS6 antibody responses in mice.

  Tobias J, Svennerholm AM, Carlin NI, Lebens M, Holmgren J. Tobias J, et al. Vaccine. 2011 Nov 8;29(48):8863-9. doi: 10.1016/j.vaccine.2011.09.096. Epub 2011 Oct 6. Vaccine. 2011. PMID: 21983363

• Strategies to overexpress enterotoxigenic Escherichia coli (ETEC) colonization factors for the construction of oral whole-cell inactivated ETEC vaccine candidates.

  Tobias J, Svennerholm AM. Tobias J, et al. Appl Microbiol Biotechnol. 2012 Mar;93(6):2291-300. doi: 10.1007/s00253-012-3930-6. Epub 2012 Feb 16. Appl Microbiol Biotechnol. 2012. PMID: 22350259 Review.

• Construction and expression of immunogenic hybrid enterotoxigenic Escherichia coli CFA/I and CS2 colonization fimbriae for use in vaccines.

  Tobias J, Svennerholm AM, Holmgren J, Lebens M. Tobias J, et al. Appl Microbiol Biotechnol. 2010 Jul;87(4):1355-65. doi: 10.1007/s00253-010-2577-4. Epub 2010 Apr 20. Appl Microbiol Biotechnol. 2010. PMID: 20405124

• Construction of non-toxic Escherichia coli and Vibrio cholerae strains expressing high and immunogenic levels of enterotoxigenic E. coli colonization factor I fimbriae.

  Tobias J, Lebens M, Bölin I, Wiklund G, Svennerholm AM. Tobias J, et al. Vaccine. 2008 Feb 6;26(6):743-52. doi: 10.1016/j.vaccine.2007.12.009. Epub 2007 Dec 26. Vaccine. 2008. PMID: 18191006

• Vaccines against enterotoxigenic Escherichia coli.

  Svennerholm AM, Tobias J. Svennerholm AM, et al. Expert Rev Vaccines. 2008 Aug;7(6):795-804. doi: 10.1586/14760584.7.6.795. Expert Rev Vaccines. 2008. PMID: 18665777 Review.

Cited by

• The adjuvant double mutant Escherichia coli heat labile toxin enhances IL-17A production in human T cells specific for bacterial vaccine antigens.

  Leach S, Clements JD, Kaim J, Lundgren A. Leach S, et al. PLoS One. 2012;7(12):e51718. doi: 10.1371/journal.pone.0051718. Epub 2012 Dec 20. PLoS One. 2012. PMID: 23284753 Free PMC article.

• The Diversity of Escherichia coli Pathotypes and Vaccination Strategies against This Versatile Bacterial Pathogen.

  Pokharel P, Dhakal S, Dozois CM. Pokharel P, et al. Microorganisms. 2023 Jan 30;11(2):344. doi: 10.3390/microorganisms11020344. Microorganisms. 2023. PMID: 36838308 Free PMC article. Review.

• A combined vaccine approach against Vibrio cholerae and ETEC based on outer membrane vesicles.

  Leitner DR, Lichtenegger S, Temel P, Zingl FG, Ratzberger D, Roier S, Schild-Prüfert K, Feichter S, Reidl J, Schild S. Leitner DR, et al. Front Microbiol. 2015 Aug 11;6:823. doi: 10.3389/fmicb.2015.00823. eCollection 2015. Front Microbiol. 2015. PMID: 26322032 Free PMC article.

• Development of stable Vibrio cholerae O1 Hikojima type vaccine strains co-expressing the Inaba and Ogawa lipopolysaccharide antigens.

  Karlsson SL, Ax E, Nygren E, Källgård S, Blomquist M, Ekman A, Benktander J, Holmgren J, Lebens M. Karlsson SL, et al. PLoS One. 2014 Nov 14;9(11):e108521. doi: 10.1371/journal.pone.0108521. eCollection 2014. PLoS One. 2014. PMID: 25397871 Free PMC article.

• Role of overexpressed CFA/I fimbriae in bacterial swimming.

  Cao L, Suo Z, Lim T, Jun S, Deliorman M, Riccardi C, Kellerman L, Avci R, Yang X. Cao L, et al. Phys Biol. 2012 Jun;9(3):036005. doi: 10.1088/1478-3975/9/3/036005. Epub 2012 May 4. Phys Biol. 2012. PMID: 22562964 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • ClinicalKey
  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations Database

• Miscellaneous

  • NCI CPTAC Assay Portal